Literature DB >> 16827770

Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.

I Z MacKenzie1, J Findlay, K Thompson, F Roseman.   

Abstract

Documented routine antenatal anti-D prophylaxis was given to 90% and 81-87% of eligible women at 28 and 34 weeks of gestation, respectively, during the early 1990s and early 2000s. With increasing experience and education, a significant improvement in the timing of the first (OR 0.26, 95% CI 0.16-0.41: P < 0.0001) and second injections (OR 0.40, 95% CI 0.26-0.61: P < 0.0001) occurred during the latter period. Despite these improvements, there was no reduction in the sensitisation rate at 0.4%. However, this low rate occurred despite significant proportions of women delivering more than 42 days after the second injection. Fifteen of the 16 sensitised women had received routine antenatal prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827770     DOI: 10.1111/j.1471-0528.2006.00988.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  4 in total

Review 1.  The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.

Authors:  Giancarlo Maria Liumbruno; Angelo D'Alessandro; Federica Rea; Vanessa Piccinini; Liviana Catalano; Gabriele Calizzani; Simonetta Pupella; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2010-01       Impact factor: 3.443

2.  A new fetal RHD genotyping test: costs and benefits of mass testing to target antenatal anti-D prophylaxis in England and Wales.

Authors:  Ala Szczepura; Leeza Osipenko; Karoline Freeman
Journal:  BMC Pregnancy Childbirth       Date:  2011-01-18       Impact factor: 3.007

3.  Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis.

Authors:  J M Koelewijn; M de Haas; T G M Vrijkotte; C E van der Schoot; G J Bonsel
Journal:  BJOG       Date:  2009-06-17       Impact factor: 6.531

Review 4.  Appropriate provision of anti-D prophylaxis to RhD negative pregnant women: a scoping review.

Authors:  Trina M Fyfe; M Jane Ritchey; Christorina Taruc; Daniel Crompton; Brian Galliford; Rose Perrin
Journal:  BMC Pregnancy Childbirth       Date:  2014-12-10       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.